These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 11565394)

  • 21. Incidences and trends of second cancers in female breast cancer patients: a fixed inception cohort-based analysis (United States).
    Yu GP; Schantz SP; Neugut AI; Zhang ZF
    Cancer Causes Control; 2006 May; 17(4):411-20. PubMed ID: 16596293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re: Recent trends in breast cancer among younger women in the United States.
    Tarone RE
    J Natl Cancer Inst; 2009 May; 101(9):691-2; author reply 692-3. PubMed ID: 19401551
    [No Abstract]   [Full Text] [Related]  

  • 24. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A decline in breast-cancer incidence.
    Kliewer EV; Demers AA; Nugent ZJ
    N Engl J Med; 2007 Aug; 357(5):509-10; author reply 513. PubMed ID: 17674464
    [No Abstract]   [Full Text] [Related]  

  • 26. U.S. cancer incidence: prostate cancer and breast cancer are most common.
    J Environ Health; 2004 Mar; 66(7):61, 63. PubMed ID: 15032116
    [No Abstract]   [Full Text] [Related]  

  • 27. Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort.
    Jacobs EJ; Thun MJ; Connell CJ; Rodriguez C; Henley SJ; Feigelson HS; Patel AV; Flanders WD; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):261-4. PubMed ID: 15668504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is family history of breast cancer a marker of susceptibility to exposures in the incidence of de novo adult acute leukemia?
    Rauscher GH; Sandler DP; Poole C; Pankow J; Shore D; Bloomfield CD; Olshan AF
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):289-94. PubMed ID: 12692102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in breast cancer incidence rates.
    Patani N; Jouhra F; Mokbel K
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):742. PubMed ID: 18349300
    [No Abstract]   [Full Text] [Related]  

  • 30. Alcohol consumption and breast cancer risk in the Women's Health Study.
    Zhang SM; Lee IM; Manson JE; Cook NR; Willett WC; Buring JE
    Am J Epidemiol; 2007 Mar; 165(6):667-76. PubMed ID: 17204515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is the incidence of breast cancer declining?
    MacMahon B; Cole P
    Epidemiology; 2008 Mar; 19(2):268-9. PubMed ID: 18277162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent controversies in mammography screening for breast cancer.
    McTiernan A
    Medscape Womens Health; 2002; 7(2):3. PubMed ID: 12142859
    [No Abstract]   [Full Text] [Related]  

  • 33. Urinary melatonin levels and breast cancer risk.
    Schernhammer ES; Hankinson SE
    J Natl Cancer Inst; 2005 Jul; 97(14):1084-7. PubMed ID: 16030307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Why is the incidence of breast cancer increasing?].
    Olsen J
    Ugeskr Laeger; 1997 Nov; 159(48):7115. PubMed ID: 9417713
    [No Abstract]   [Full Text] [Related]  

  • 35. [Incidence, mortality and survival rates of female breast cancer in Tianjin, China].
    Chen K; He M; Dong S; Wang J
    Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):573-5. PubMed ID: 12667329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temporal trends in breast cancer mortality by state and race.
    DeSantis C; Jemal A; Ward E; Thun MJ
    Cancer Causes Control; 2008 Jun; 19(5):537-45. PubMed ID: 18270799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast cancer.
    Miller BA; Feur EJ; Hankey BF
    N Engl J Med; 1992 Dec; 327(24):1756-7. PubMed ID: 1435922
    [No Abstract]   [Full Text] [Related]  

  • 38. [Low sensitivity, miscalculated statistics are two of the weakest points of the Malmö study].
    Tabár L; Fagerberg G
    Lakartidningen; 1988 Nov; 85(47):4055-6. PubMed ID: 3200014
    [No Abstract]   [Full Text] [Related]  

  • 39. The breast cancer problem.
    Potter JF
    GP; 1967 Jan; 35(1):105. PubMed ID: 6066663
    [No Abstract]   [Full Text] [Related]  

  • 40. Quantifying the breast cancer threat.
    Hosp Health Netw; 1994 Dec; 68(23):17. PubMed ID: 7951452
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.